header

Publikationen

Prof. Dr. Bernd Joachim Krause

Originalarbeiten in wissenschaftlichen Fachzeitschriften

2016

 

 

Evaluation of prostate cancer with 11C- and 18F-Choline PET/CT: Diagnosis and initial staging

Nitsch S, Hakenberg OW, Heuschkel M, Dräger D, Hildebrandt G, Krause BJ, Schwarzenböck SM

J Nucl Med 2016;57(Suppl 3):38S-42S

 

Radionuklidtherapie von Knochenmetastasen mittels Radium-223; S1 Leitlinie

Pöppel, TD, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Mitterhauser M, Scheidhauer K, Schenck M, Sonnenschein W, Gabriel M

Nuklearmedizin 2016;55(5):177-186

 

Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate Cancer

Schwarzenböck SM, Eiber M, Kundt G, Retz M, Sakretz M, Kurth J, Treiber U, Nawroth R, Rummeny EJ, Gschwend JE, Schwaiger M, Thalgott M, Krause BJ

Eur J Nucl Med Mol Imaging 2016;43(12):2105-2113

 

The 2015 Revised American Thyreoid Association guidlines for the management of medullary thyreod carcinoma: the „evidence-based“ refusal to endorse them by EANM due to „not evidence-based“ marginalization oft he role of Nuclear Medicine

Treglia G, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Verburg FA, Luster M

Eur J Nucl Med Mol Imaging 2016;43:1486-1490

 

Beta-Amyloid-PET-Bildgebung des Gehirns

Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, Coenen HH, la Fougére C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Schreckenberger M, Tatsch K, Langen K-J, Sabri O

Nuklearmedizin 2016;55(4):129-137

 

Therapie mit 177Lu-PSMA-617 – Dosimetrie und Nachsorge beim metastasierten kastrationsresistenten Prostatakarzinom

Fendler WP, Kratochwill C, Ahmadzadehfar H, Rahbar K, Baum RP, Schmidt M, Pfestroff A, Lützen U, Prasad V, Heizel A, Heuschkel M, Ruf J, Bartenstein P, Krause BJ

Nuklearmedizin 2016;55(3):123-128

 

Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologies

Schwarz T, Seidl C, Schiemann M, Senekowitsch-Schmidtke R, Krause BJ

Nuclear Medicine and Biology 2016;43:355-359

 

Non-invasive assessment of inter- and intrapatient variability of integrin expression in metastasized prostate cancer by PET

Beer AJ, Schwarzenböck S, Zantl N, Sovatzoglou M, Maurer T, Watzlowik P, Kessler H, Wester HJ, Schwaiger M, Krause BJ

Oncotarget 2016;7(19)28151-9

 

Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasm in Germany: A multi-institutional registry study with prospective follow-up

Hörsch D, Ezzidin S, Haug A, Gratz KF, Dunkelmann S, Miederer M, Schreckenberger M, Krause BJ, Bengel FM, Bartenstein P, Biersack HJ, Pöpperl G, Baum RP

Eur J Cancer 2016;58:41-51

 

18F-fluoroethyl-l-thyrosine (FET) PET to delineate tumor residuals after glioblastoma resection: A comparison to standard postoperative MRI

Buchmann N, Kläsner B, Gempt J, Bauer JS, Pyka T, Delbridge C, Meyer B, Krause BJ, Ringel F

World Neurosurg. 2016;89:420-426

 

 

Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer

Verburg FA, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Luster M; EANM and the EANM Thyroid Committee.

Eur J Nucl Med Mol Imaging. 2016;43(6):1001-1005

 

PET/CT with 11 C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta analysis and critical review of available data

Fani S, Minozzi S, Castellucci P, Balduzzi S, Herrmann K, Krause BJ, Oyen W, Chiti A

Eur J Nucl Med Mol Imaging 2016;43:55-69

 

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1

Sathe A, Koshy N, Schmid SC, Thalgott M, Schwarzenböck SM, Krause BJ, Holm PS, Gschwend JE, Retz M, Nawroth R

J Urol 2016;195:771-779                                                          

 

Cardiac FDG-PET: a straight forward tool with high potential

Lang CI, Krause BJ, David R

Eur Heart J Cardiovasc Imaging 2016;17:130-131

 

Comparison of [11C]Choline ([ 11C]CHO) and [18F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model

Schwarzenböck SM, Schmeja P, Kurth J, Souvatzoglou M, Nawroth R, Treiber U, Kundt G, Berndt S, Graham K, Senekowitsch-Schmidtke R, Schwaiger M, Ziegler SI, Dinkelborg L, Wester HJ, Krause BJ

Mol Imaging Biol 2016;18(3):393-401

 

 

 

 

2015

 

The relative importance of imaging markers fort he prediction of Alzheimer´s disease dementia  in mild cognitive impairment – beyond classical regression

Teipe, SJ, Kurth J, Krause BJ

Neuroimage Clin:2015;21(8):583-593

 

124I-PET Assessment of human sodium iodide symporter reporter gene activity for highly sensitive in vivo monitoring of teratoma formation in mice

Lehner S, Lang C, Kaissis G, Todica A, Zacher MJ, Boening G, Spitzweg C, Herbach N, Franz WM, Krause BJ, Steinhoff G, Bartenstein P, Hacker M, David R

Mol Imaging Biol 2015;  [Epub ahead of print]

 

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

Thalgott M, Rack B, Eiber M, Souvatzoglou M, Heck MM, Kronester C, Andergassen U, Kehl V, Krause BJ, Gschwend JE, Retz M, Nawroth R

BMC Cancer 2015;15:458

 

Wie schreibe ich eine gute Übersichtsarbeit?

Krause BJ, Khan C, Ntoch G

Nuklearmedizin 2015;54(2):69-74                                              

 

Robust, fully automatic delineation of the head contout by sterotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy

Lange C, Kurth J, Seese A, Schwarzenböck S, Steinhoff K, Umland-Seidler B, Krause BJ,

Brenner W, Sabri O, Hesse S, Buchert R

Eur Rad 2015 ;  [Epub ahead of print]                           

 

Circulating tumor cells versus objective response assessment predicting survival in metastastic castration-resistant prostate cancer patients trated with docetaxel chmeothyrepy

Thalgott M, Heck MM, Eiber M, Souvatzoglou M, Hatzichristodoulou G, Kehl V, Krause BJ, Rack B, Retz M, Gschwend JE, Andergassen U, Nawroth R

J Cancer Res Clin Oncol 2015;141(8):1457-1464            

 

Peptidrezeptor-Radionuklidtherapie Somatostatinrezeptor-exprimierender Tumore

DGN Leitlinie (S1)       

Poeppel TD, Boy C, Kotzerke J, Buchmann I, Ezziddin S, Scheidhauer K, Krause BJ, Schmidt D, Amthauer H, Rösch F, Nagarajah, Führer D, Lahner H, Pöpperl G, Hörsch D, Walter MA, Baum RP

Nuklearmedizin 2015;54(1):1-11 

                                  

Positronenemissinstomographie 2013 in Deutschland

Kotzerke J, Oehme L, Grosse J, Hellwig D, Arbeitausschuss PET der DGN u. a. Krause BJ

Nuklearmedizin 2015;54(2):53-59

                                              

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ.

Eur J Nucl Med Mol Imaging 2015;42(2):328-354

 

           

Comparison of [11C]Choline ([ 11C]CHO) and S(+)-β-Methyl-[ 11C]Choline ([ 11C]SMC) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model

Schwarzenböck SM, Gertz J, Souvatzoglou M, Kurth J, Sachs D, Nawroth R, Treiber U, Schuster T, Senekowitsch-Schmidtke R, Schwaiger M, Ziegler SI, Henriksen G, Wester HJ, Krause BJ

Mol Imaging Biol. 2015;17(2):248-256    

                                  

Prediction of Parkinson´s disease subsequent to severe depression: a ten-year follow-up study

Walter U, Heilmann R, Kaulitz L, Just T, Krause BJ, Benecke R, Höppner J

J neural Transm 2015;122(6):789-797                                       

 

Repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment-refractoty auditory hallucinations and major self-mutilation

Schulz T, Berger Ch, Krecklow B, Kurt J, Schwarzenboeck S, Foley P, Thome J, Krause BJ, Hoeppner J

J Neural Transm 2015;122(Suppl.1):19-23                                 

 

2014

 

CT-based attenuation correction in I-123-Ioflupane SPECT

Lange C, Seese A, Schwarzenböck S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Kurth J, Hesse S, Buchert R

PLOS one 2014;9(9):e108238

 

Welche bildgebenden Verfahren sind in der Demenz-Diagnostik sinnvoll?

Sakretz M, Kurth J, teipel S, Krause BJ

DNP-Der Neurologe&Psychiater 2014;15(10)

 

11C-Choline PET/ pathology image coregistration in primary localized prostate cancer

Grosu AL, Weirich G, Wendl C, Prokic V, Kirste S, Geinitz H, Souvatzoglou M, Gschwend JE, Schwaiger M, Molls M, Weber WA, Treiber U, Krause BJ

Eur J Nucl Med Mol Imaging 2014;41(12):2242-2248                  

 

In-vivo of the acute retention of stem cell derivatives and fribroblasts after

intrmyocardial transplantation

Lang, C, Lehner S, Todica A, Boening G, Zachert M, Franz WM, Krause BJ, Bartenstein P,

Hacker M, David R

Eur J Nucl Med Mol Imaging 2014;41(12):2325-2336                  

 

Ösophagus- und Magenkarzinom – Staging und Bildgebung

Schwarzenböck S, Krause BJ, Ebert M, Grenacher L

Klinikarzt 2014;43:348-353

 

Prognostic Value of 11C-Choline PET/CT and CT for Predicting Survival of Bladder

Cancer Patients Treated with Radical Cytectomy

Mauerer T, Horn T, Souvatzoglou M, Eiber M, Beer AJ, Heck MM, Haller B, Gschwend JE,

Schwaiger M, Treiber U, Krause BJ

Urol Int 2014;93(2):207-213                                                      

 

Preoperative lymph node Staging in patients with primary prostate cancer: Comparison and correlation of quantitative imaging parameters in duffusion weighted imaging [11C]-coline PET/CT

Vag T, Heck M, Beer AJ, Souvatzoglou M, Weirich G, Holzapfel K, Krause BJ, Schwaiger M, Eiber M

Eur Radiol 2014;24(8):1821-1826                                              

 

Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells

Elsner A, Lange F, Fitzner B, Heuschkel M, Krause BJ, Jaster R

World J of Gastro2014;20(24):7914-7925                                  

 

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C] choline positron emission tomography/ computed tomography for preoperative lymph node staging in prostate cancer patients

Heck M, Souvatzoglou M, Retz M, Nawroth R, Kübler H, Maurer T, Thalgott M, Gramer BM, weirich G, Rondak IC, Rummeny EJ, Schwaiger M, Gschwend JE, Krause BJ, Eiber M

Eur J Med Mol Imaging 2014;41:694-701                                  

 

Cholinergic basal forebrain atrophy predicts amyloidburden in Alzheimer`s disease

Teipe S, Heinsen H, Amaro Jr. E, Grinberg LT, Krause BJ, Grothe M, Alzheimer`s Disease Neuroimaging Initiative

Neurobiology of Aging 2014;35:482-491                                    

 

European Association of Nuclear medicine: adapt the present, shape the future

Frangos S, Knapp W, - on behalf of the EANM Executive Committee (Krause BJ)

Eur J Nucl Med Mol Imaging 2014;41:590-591                           

 

Quality criteria for multidisciplinary oncology guidelines – the ECCO multidisciplinary clinical guidlines forum

Schrijvers D, van den Velde C, Bregni M, Caraceni A, Cardoso F, Erdem S, Geldenborn H, Grisold W, Honore PGH, Krause BJ, Licitra L, Mansel R, Margilies H, Parsons K, Poston G, Valentini V, Zola P

Eur Assoc Neurooncol Mag 2014;4(1):6-8

 

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer

Thalgott M, Horn T, Heck M, Maurer T, Eiber M, retz M, Autenrieth M, Herkommer K, Krause BJ, Gschwend JE, Treiber U, Kübler HR

J of Hema & Oncol 2014;7:20                                                  

 

Molekulare multimodale Hybridbildgebung des Prostata- und Blasenkarzinoms

Maurer T, Eiber M, Krause BJ  

Der Urologe 2014;53:469-483                                                   

 

Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects

Grothe, MJ, Ewers M, Krause B, Heinsen H, Teipel SJ, für the Alzheimer´s Disease Neuroimaging Initiative

Alzheimer`s & Dementia 2014;10(Suppl. 5):S344-353                                        

 

2013

 

Perfusion brain imaging with SPECT-technique. German Guidline S1

Kranert T, Menzel C, Bartenstein P, Brust P, Coenen HH, Krause BJ, Kuwert T, Sabri O, Schreckenberger M, Tatch K, Grünwald F

Nuklearmedizin 2013;52(5):157-162                               

 

Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates

Krause BJ, Souvatzoglou M, Treiber U.

Urol Oncol 2013 May;31(4):427-35                                

 

Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050

Smolarz K, Krause BJ, Graner FP, Wagner FM, Wester HJ, Sell T, Bacher-Stier C, Fels L, Dinkelborg L, Schwaiger M.

Eur J Nucl Med Mol Imaging 2013;40(12):1861-1868      

 

[11C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model

Schwarzenböck S, Sachs D, Souvatzoglou M, Schuster T, Nawroth R, Weirich G, Treiber U, Wester HJ, Ziegler S, Schwaiger M, Senekowitsch-Schmidtke R, Krause BJ.

Nuklearmedizin 2013 Aug 8;52(4):141-7                         

 

 

Molecular imaging of dementia

Kurth J, Sakretz M, Teipel S, Krause BJ

Geriatric Mental Health Care 2013;1(3):56-62

 

Das Peniskarzinom

Protzel C, Kakies C, Schwarzrnböck S, Kuhnt T, Ebersdobler A, Krause BJ, Hakenberg OW

Der Onkologe 2013;19(2):149-162                                             

 

Molecular imaging techniques in the diagnosis of dementia

Kurt J, Kilimann I, Krause BJ, Teipel S

Nervenheilkunde2013;32:725-732                                             

 

Tumour volume delineation in prostate cancer assessed by (11C)choline PET/C/: validation with surgical specimens

Bundschuh RA, Wendl CM, Weirich G, Eiber M, Sovatzoglou M, Treiber U, Küberler H, Maurer T, Gschwend JE, Geinitz H, grosu AL, Ziegler SI, Krause BJ

Eur J Nucl Med Mol Imaging 2013;40(6):824-831           

 

Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer

Schwarzenböck S, Kurth J, Gocke C, Kuhnt T, Hildebrandt G, Krause BJ

Eur J Nucl Med Mol Imaging 2013;40(Suppl 1):28-35      

 

(S)-4-(3-18F-Fluoropropyl)-L-Glutamic Acid: An 18F-Labaled Tumor-Specitic Probe for PET/CT Imaging-Dosimetry

Smolarz K, Krause BJ, Graner FP, Wagner FM, Hultsch C, Bacher-Stier C, Sparka RB, Ramsay S, Fels LM, Nunkelborg LM, Schwaiger M

J Nucl Med 2013;54(6):861-866

 

Imaging of prostatate cancer with PET/CT and radioactively labeled choline derivates

Krause BJ, Souvatzoglou M, Treiber U

Urol Oncol 2013;31(4):427-435

                                                                                 

 

2012

 

S3-guidline-diagnosis and treatment of gastric carcinoma:relevance for radiologic imaging

Grenacher L, Schwarz M, Lordick F, Krause BJ, Roecken C, Moening S, Ebert M, Jenssen C, Kauczor HU, Moehler M, Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)

Rofo 2012;184(8):706-12                                                          

         

PET/CT and choline: diagnosis and staging

Farsad M, Schwarzenböck S, Krause BJ

Q J Nucl Med Mol Imaging 2012;56(4):343-53                

 

SNM/EANM Guidline for Guideline Development 6.0

Delbeke D, Chiti A, Christian P, Darcourt J, Donohoe K, Flotats, Krause BJ, Royal HD,

J Nucl Med Technol 2012;40:283-9                                                                              

 

18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions

Buck D, Förschler A, Lapa C, Schuster T, Vollmar P, Korn T, Nessler S, Stadelmann C, Drzezga A, Buck AK, Wester HJ, Zimmer C, Hemmer B, Krause BJ

J Nucl Med 2012;53(8):1269-76                                                

 

Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy

Maurer T, Souvatzoglou M, Kübler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U

Eur Urol 2012;61(5):1031-8                                                      

 

Choline PET and PET/CT in primary diagnosis and staging of prostate cancer

Schwarzenböck S, Souvatzoglou M, Krause BJ

Theranostics 2012;2(3):318-30                                                 

 

Value of PET/CT ans MR Lymphography in Treatment of Prostate Cancer Patients with Lymph Node Metastases

Fortuin AS, Daserno WMLLG, Meijer HJM, Jager GJ, Takahashi S, Debats OA, Reske SN, Schick C, Krause BJ, van Oort I, Witjes AJ, Hoogeveen YL, van Lin ENJ, Baretsz JO

Int J Radiation Oncol Biol Phys 2012;84(3):712-8                      

 

Diagnostic efficary of (11C)Choline Positron Emission Tomography/ Computed Tomography compraed with conventional Computed Tomography in lymph node staging of patients wirt bladder cancer prior to rasdical cystectomy

Maurer T, Souvatzoglou M, Kübler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U

Eur Urol 2012;61(5):1031-38                                         

 

 

2011

 

Letter to the Editor:

Re: Mottet N, Bellmunt J, Bolla M, et all: EAU Guidelines on orostate Caner Part II: Treatment of advanced, relapsing and gastration-resistant prostate Caner

Eur Urol 2011;60:e37-e38                                                                                                       

 

PET/CT for the diagnosis, staging and restaging of prostatate cancer

Souvatzoglou M, Gärtner F, Schwarzenböck S, Beer AJ, Schwaiger M, Krause BJ

Imaging in Medicine 2011;3(5):571-585                         

 

Welche neuen PET-Tracer braucht die Strahlentherapie?

Schwarzenböck S, Herrmann K, Gärtner F, Kläsner B, Souvatzoglou M, Krause BJ

Der Nuklearmediziner 2011;34(2);99-108

 

18F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can do

Herrmann K, Benz MR, Krause BJ, Pomykala KL, Buck AK, Czemin J.

Q J Nucl Med Mol Imaging 2011;55(6):620-32 

 

S6K1 and 4E-BP1 are independent regulated and control cellular growth in Bladder cancer

Nawroth R, Stellwagen F, Schulz WA, Stoehr R, Hartmann A, Krause BJ, Gschwend JE, Retz M

PLoS One 2011;6(11):e27509,

 

Prognistic value of (18F)-Flurop-Deoxy-Glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma

Essler M, Link A, Belloni B, Mirceva V, Souvatzoglou M, Thaler M, Haller B, Hein R, Krause BJ

PloS One 2011;6(9):e24632,

 

Curative treatment of oesophageal carcinoma: current options and future developments

Wolf MC, Stahl M, Krause BJ, Bonavina C, Bruns C, Belka C, Zehentmayr F

Radiat Oncol 2011;6:55 

 

Molecular imaging of proliferation and glucose utilization: utility for monotoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer

Ott K, Hermann K, Schuster T, Lange R, Becker K, Wieder HA, Wester HJ, Siewert JR, Büschenfelde CM, Buck AK, Wilhelm D, Ebert MP, Pechel C, Schwaiger M, Lordick F, Krause BJ

Ann Surg Oncol 2011;18(12):3316-23 

 

Positron emission tomography – current role in the diagnostic and treatment of upper gastrointestinal carcinomas

Lordick F, Ott K, Krause BJ

Dtsch. Med. Wochenschr 2011;136(20):1061-6 

German S3-guidline "Diagnosis and treatment of esophagogastric cancer"Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C; AWMF

Z Gastroenterol. 2011;49(4):461-531 

 

The sensitivity of (11)Choline PET/CT to localize prostate cancer depends on the tumor configuration

Souvatzoglou M, Weirich G, Schwarzenboeck S, Maurer T, Schuster T, Bundschuh RA, Eiber M, Herrmann K, Kuebler H, Wester HJ, Hoefler H, Gschwend J, Schwaiger M, Treiber U, Krause BJ

Clin Cancer Res 2011;17(11):3751-9             

 

         

Infuence of (11)Choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochjemical recurrence of prostate cancer

Souvatzoglou M, Krause BJ, Pürschel A, Thamm R, Schuster T, Buck AK, Zimmermann F, Molis M, Schwaiger M, Geinitz H

Radiother Onco 2011;99(2):193-200              

 

18F-FDG-PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the municon II trial

Meyer zum Büschenfelde C, Herrmann K, Schuster T, Geinitz H, Langer R, Becker K, Ott K, Ebert M, Zimmermann F, Friess H, Schwaiger M, Peschel C, Lordick F, Krause BJ

J Nucl Med 2011;52(8):1189-96  

 

German Guidelines for brain-tumor imaging by PET ans SPECT using labeled amino acids

Langen KJ, Bartenstein P, Boecker H, Brust P, Coenen HH, Drzezga A, Grünwald F, Krause BJ, Kuwert T, Sabri O, Tatsch K, Weber WA, Schreckenberger M

Nuklearmedizin 2011;50(4):167-73   

 

Radionuclide and Hybrid Imaging of Recurrent Prostate Cancer
Beer A, Eiber M, Souvatzoglou M, Schwaiger M, Krause BJ

Lancet Oncology 2011;12(2):181-91

 

The Role of choline positron emission tomography/computed tomography in the management of patients with prostatate-spcific antigen progression after radical treatment of prostate cancer

Picchio M, Briganti A ,Fanti S, Heidenreich A, Krause BJ, Messa C, Montorsi F, Reske SN, Thalmann GN

Eur Urology 2011;59(1):51-60, 

 

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in 11C-Choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer

Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, Maurer T, Kübler H, Wester HJ, Gaa J, Krause BJ

Mol Imag Biol  2011;13(2):352-61, 

 

Comparison of different SUV-based methods for prediction of response to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI

Herrmann K, Bundschuh RA, Rosenberg R, Schmidt S, Praus C, Souvatzoglou M, Becker K, Schuster T, Essler M, Wieder HA, Friess H, Ziegler SI, Schwaiger M, Krause BJ

Mol Imag Biol 2011;13(5):1011-9  

 

Long-term exposure to high-altitude chronic hypoxia during gestation induced neonatal pulmonary hypertension at sea level

Herrera EA, Requelme RA, Ebensperger G, Reyes RV, Ulloa CE, Cabello G, Krause BJ, Parer JT, Giussani DA, Loanos AJ

Am J Physiol regul Comp Physiol 2010;299(6):R1676-84

 

 

Nach oben